Cytokinetics | CYTK - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Amgen USD 9.9B 340M 2025-12
Arca Biopharma 0 0 2025-03
Bayer EUR 11.44B 1.78B 2025-12
Biogen USD 2.28B 250M 2025-12
Brainstorm Cell Therapeutics 0 0 2025-03
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Cytokinetics USD 17.76M 15.83M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Exelixis USD 598.66M 860K 2025-12
Geron USD 48.02M 820K 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12